R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Administrative Assistant 1

Administrative SupportConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA$90k - $108k

About the Job

Requirements

  • A minimum of 3 years of experience in executive administrative support, coordination, or project management, preferably in a global or matrixed environment.
  • The ability to manage multiple projects and shifting priorities for senior leadership.
  • Experience managing complex scheduling and travel logistics.
  • Strong organizational skills, attention to detail, and discretion with confidential information.
  • The ability to work independently with minimal direction and manage time effectively.
  • Written and verbal communication skills, including the ability to engage with senior stakeholders.
  • Proficiency in Microsoft Office, including Outlook, SharePoint, Excel, and PowerPoint, and collaboration tools such as Microsoft Teams.

Responsibilities

  • Manage complex, multi-time-zone calendar scheduling for the Pharmaceutical Development leadership team, optimizing time against strategic priorities.
  • Coordinate domestic and international travel, prepare detailed itineraries, and ensure timely submission and reconciliation of expenses.
  • Prepare meeting agendas, briefing materials, and background documents; ensure follow-up on action items and decisions.
  • Anticipate needs, prioritize incoming requests, and deploy appropriate resources to ensure timely execution.
  • Maintain organized documentation, trackers, and communication systems that support executive decision-making and visibility.
  • Prepare detailed onboarding itineraries and materials for incoming Vice Presidents.
  • Draft and distribute internal communications related to promotions, new hires, leadership changes, and policy updates.
  • Compile confidential data for quarterly board and executive reports, including headcount, attrition, and diversity metrics.
  • Track and manage compliance and mandatory training deadlines for the leadership team.
  • Prepare agendas and pre-read materials for performance calibration, succession planning, and talent review meetings.
  • Manage day-to-day coordination of Pharmaceutical Development and Manufacturing leadership team priority projects and initiatives across regions and disciplines.
  • Coordinate cross-functional working groups for harmonization and transformation efforts, driving accountability and follow-through.
  • Maintain integrated tracking of global initiatives, programs, and workstreams, partnering with regional leaders to ensure alignment on milestones and deliverables.
  • Develop status reports, dashboards, and executive summaries for leadership review.
  • Identify risks, blockers, and escalation points; proactively problem-solve with stakeholders and keep leadership informed.
  • Support strategic planning processes, including preparation of materials, tracking action items, and coordinating follow-up meetings.
  • Draft, edit, and format communications, presentations, and reports for review and distribution to leadership.
  • Coordinate logistics for leadership meetings, town halls, and planning sessions.
  • Serve as a point of contact between the Pharmaceutical Development and Manufacturing leadership team and internal or external stakeholders, as appropriate.

Desired Qualifications

  • Corporate or agency experience is preferred.
  • Prior experience supporting senior leaders or C-suite executives is strongly preferred.
  • Experience managing multiple projects and shifting priorities for senior leadership.
  • Experience with complex scheduling and travel logistics.
  • Proficiency in Microsoft Office (Outlook, SharePoint, Excel, PowerPoint) and collaboration tools such as Microsoft Teams.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs